Search Results

Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.

• Authors : Perea-Jacobo R; Laboratorio de Epidemiología y Ecología Molecular, Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Ensenada, Facultad de Ciencias Marinas, Universidad Autónoma de Baja California, Ensenada.; Muñiz-Salazar R

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*administration & dosage ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Rifampin/Rifampin/Rifampin/*administration & dosage

• Source: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis Publisher: The Union Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic)

Record details

ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.

• Authors : Egelund EF; Isaza R; Alsultan A

Subjects: Elephants*/Elephants*/Elephants*/blood; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacokinetics ; Isoniazid/Isoniazid/Isoniazid/*pharmacokinetics

• Source: Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians [J Zoo Wildl Med] 2016 Sep; Vol. 47 (3), pp. 868-871.Publisher: American Association Of Zoo Veterinarians Country of Publication: United States NLM ID: 8915208 Publication Model: Print Cited Medium: Print

Record details

Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis.

• Authors : Schaaf HS; Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University and Tygerberg Children's Hospital, PO Box 19063, Tygerberg 7505, South Africa. ; Willemse M

Subjects: Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*pharmacokinetics ; HIV Infections/HIV Infections/HIV Infections/*complications ; Rifampin/Rifampin/Rifampin/*pharmacology

• Source: BMC medicine [BMC Med] 2009 Apr 22; Vol. 7, pp. 19. Date of Electronic Publication: 2009 Apr 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.

• Authors : Kim ES; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.

Subjects: Tuberculosis* ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/drug therapy ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/genetics

• Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Sep; Vol. 87 (9), pp. 3492-3500. Date of Electronic Publication: 2021 Mar 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.

• Authors : Ordonez AA; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacokinetics ; Lung/Lung/Lung/*diagnostic imaging ; Lung/Lung/Lung/*metabolism

• Source: Nature medicine [Nat Med] 2020 Apr; Vol. 26 (4), pp. 529-534. Date of Electronic Publication: 2020 Feb 17.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Agricola

Record details

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients.

• Authors : Thomas, Levin; Sekhar Miraj, Sonal; Surulivelrajan, Mallayasamy

Subjects: SINGLE nucleotide polymorphisms; RIFAMPIN; TUBERCULOSIS patients

• Source: Antibiotics (2079-6382); Jun2020, Vol. 9 Issue 6, p307-307, 1p

Record details

The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.

• Authors : Pepin, Xavier J. H.; Johansson Soares Medeiros, Juliana; Deris Prado, Livia

• Source: Pharmaceutics; Dec2024, Vol. 16 Issue 12, p1587, 25p

Record details

Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa.

• Authors : Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Martinson N

Subjects: Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*pharmacokinetics ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Pregnancy Complications, Infectious/Pregnancy Complications, Infectious/Pregnancy Complications, Infectious/*drug therapy

• Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Dec 07; Vol. 60 (3), pp. 1234-41. Date of Electronic Publication: 2015 Dec 07.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic Cited Medium: Internet

Record details

Population pharmacokinetics of rifampin in the treatment of Mycobacterium tuberculosis in Asian elephants.

• Authors : Egelund EF; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Isaza R

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacokinetics ; Elephants/Elephants/Elephants/*blood ; Mycobacterium tuberculosis/Mycobacterium tuberculosis/Mycobacterium tuberculosis/*drug effects

• Source: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2015 Apr; Vol. 38 (2), pp. 137-43. Date of Electronic Publication: 2014 Sep 18.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet

Record details